Maiwald Magazine

News and Releases

Maiwald Blog

15 Jun 2026 - Maiwald Blog

Shedding Light on the Black Box — AI Inventions under the Scrutiny of Art. 83 EPC

Six decisions of the EPO's Boards of Appeal use a string of cautionary tales to map the absolute floor of what patent applications for AI inventions must disclose — and ...

Continue reading

10 Jun 2026 - Maiwald Blog

File Late, Pay Licence

GPS spoofing, dual-use technology and the intellectual property question European developers must now ask

Continue reading

24 Apr 2026 - Maiwald Blog

Analysis of Examination Standards and Case Law for AI and Software-Related Inventions

I am very honored to announce that I have had the opportunity to write a book in Japanese, which has been published. The b...

Continue reading

All articles

Press Coverage

5 Dec 2025 - Press Coverage

Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement.

Royalty Pharma and Denali have entered into a $275 million financing agreement which, pursuant to a synthetic royalty agreement, is based on future net sales of tividenofusp alfa. Tividenofusp alfa is Denali’s lead investigational TransportVehicle™-enabled enzyme rep...

Continue reading

25 Aug 2025 - Press Coverage

Royalty Pharma acquires licence interest for Amgen’s Imdelltra – Maiwald advises on transaction

Royalty Pharma has acquired a royalty interest in Amgen's Imdelltra, an innovative BiTE antibody for the treatment of small cell lung cancer, from BeOne Medicines for an upfront payment of $885 million. The agreement allows BeOne to sell additional royalty rights in Imdelltr...

Continue reading

14 Jul 2025 - Press Coverage

Royalty Pharma and Revolution Medicines Sign Funding Agreements Worth Up to $2 Billion

Royalty Pharma plc and Revolution Medicines, Inc. have announced a strategic funding collaboration of up to $2 billion to support the global development and commercialization of Revolution’s RAS(ON) inhibitor portfolio, particularly the clinical advancement of lead candida...

Continue reading

Maiwald in the press

Staff News

2 Mar 2026 - Staff News

Maiwald appoints Dr. Kerstin Wolff as Partner

Maiwald, one of Germany’s leading intellectual property law firms, has appointed Dr. Kerstin Wolff as Partner effective from 1 March 2026. This appointment further strengthe...

Continue reading

29 Jan 2026 - Staff News

Maiwald appoints Martina Boidol, Dr. Anja Fux, and Sebastian Herzog as managing partners

With retroactive effect from the beginning of the new year, Maiwald, one of Germany's leading intellectual property law firms, has appointed Martina Boidol, Dr. Anja Fux, and ...

Continue reading

11 Nov 2025 - Staff News

Dr Iris Müller and Dr Gabriel Kiefl sworn in as German patent attorneys

We are pleased to announce that our colleagues

Continue reading

All Staff News

Publications

26 May 2026 - Publication

Podcast INSIGHT epi: The New Transparency Rules for Clinical Trials in the EU: Navigating Regulatory Disclosure and Patentability at the EPO and UPC

New INSIGHT epi podcast episode with Maiwald experts on clinical trial transparency and patentability In ...

Continue reading

29 Apr 2026 - Publication

Mobile foot measurement’s IP battle highlights easily overlooked step in startup journey, Managing IP, 2026

In an article for Managing IP, Dr Christian Meyer of Maiwald, in collaboration with Footprint Technologies, explains how a single process patent has had a significant impact o...

Continue reading

28 Apr 2026 - Publication

Preliminary Injunctions in German Pharmaceutical Patent Litigation, Newsletter of the AIPLA Chemical Practice Committee, Spring 2026, Volume 14, Issue 1

In his article “Preliminary Injunctions in German Pharmaceutical Patent Litigation”, published in the Newsletter of the AIPLA Chemical Practice Committee, Spring 2026, Vol...

Continue reading

All publications

Awards

18 Jun 2026 - Award

Handelsblatt Best Lawyers: Germany’s Best Lawyers 2026

In cooperation with Handelsblatt, the US specialist publisher Best Lawyers has once again identified Germany’s most renowned lawyers for the 2026 edition of “Germany’s B...

Continue reading

29 May 2026 - Award

IAM Patent 1000 Rankings 2026

Continue reading

4 May 2026 - Award

Managing IP EMEA Awards 2026

Maiwald wins two Europe Impact Case of the Year awards at the Managing IP EMEA Awards 2026 At this year...

Continue reading

All awards

Events

Thu.

2

2 Jul 2026 |Upcoming

INTA Seminar for Paralegals 2026 in Munich

On Thursday, 2 July 2026, the International Trademark Association (INTA) will host the 2026 Seminar for Paralegals in Munich – a full‑day, German‑language programme specifically tailored to paralegals working in the fields of trademarks and brand protection. The event will take place from 9:00 am to 4:00 pm at the ...

Continue reading

Mon.

21

21 Sep 2026 |Upcoming

Maiwald at the 10th Munich IP Forum

On 21–22 September 2026, the Munich IP Forum will once again bring together leading representatives from industry, private practice, the judiciary, and the patent profession in Munich. The event provides a platform for exchanging insights on the latest developments in European patent law, with a particular focus on the Unified Patent Cou...

Continue reading

Wed.

24

24 Jun 2026 |Past Event

ORIGINAL VS. IMITATION – Expert Forum on the 50th Plagiarius Awards

To mark the 50th anniversary of the “Plagiarius” negative award, Aktion Plagiarius e.V. and Maiwald are hosting a high‑level expert forum dedicated to the protection of intellectual property. The event will focus on strategies for protecting trademarks, designs and patents before national and international bodies, ...

Continue reading

Tue.

2

2 Jun 2026 |Past Event|Reports

Joint symposium with Oblon in Tokyo | 2 June 2026

Oblon and Maiwald are pleased to invite you to a complimentary joint international symposium on: U.S. and European patent practice: Important Aspects for Practitioners. Date and venue: Tuesday, 2 June 2026, 13:00 JST, at the AP Marunouchi, Tokyo

Continue reading

All events